Arkolith/Insider Trading/TVTX/Form 4

Cline Christopher R.

CHIEF FINANCIAL OFFICERTravere Therapeutics, Inc. (TVTX) · full profile →Form 4 · filed May 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$115K
Net Open-Market Flow
-$115K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 6, 2026Sell(S)310$43.95$14K119K
May 5, 2026Sell(S)2K$46.65$102K119K
May 4, 2026Option exercise(M)4K—$0121K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 4, 2026Grant(A)9K—$09K
May 4, 2026Option exercise(M)4K—$04K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001943192-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML